Orbital Therapeutics

Orbital Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2022. The company is focused on advancing RNA-based medicines to treat a variety of human diseases, excluding RNAi therapeutics. Its mission is to enhance global health by leveraging RNA technologies to develop innovative treatments. The company has developed a comprehensive platform that integrates RNA technology, delivery methods, data science, and automation. This platform aims to create a diverse portfolio of medicines, with initial focuses on next-generation vaccines, immunomodulation therapies, and protein replacement treatments. Orbital Therapeutics is dedicated to improving the durability of RNA therapeutics and enhancing delivery to various cell types and tissues. With significant funding, including a $270 million Series A round, Orbital Therapeutics is positioned to innovate within the biotech industry. The company is led by a team of experts in genetic medicine and RNA development, fostering collaboration to drive its mission forward.

Research Cambridge, United States ~17 employees Private ยท Series A

Work at Orbital Therapeutics in HR or recruiting? Claim this page

Employees
17
0% in the 3 months to Sep 2026
Revenue / employee
$176K
Revenue ~$3M
Total funding
$270M
Last round Series A, Apr 2023
12-month attrition
63.7%
Tech: 37.5%
H1B filings, FY2024
1
Sponsors visas

Headcount trend

Orbital Therapeutics went from 63 employees in Oct 2024 to 17 in Sep 2026. Apr to Sep 2026: 0 people joined, 3 left.

Funding rounds

Total funding$270M
Funding rounds1
Investors12

Org structure

Headcount by department

Other13
Operations2
Finance1
Engineering1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering1

Peer reviews

Worked with someone at Orbital Therapeutics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Orbital Therapeutics FAQ

How many employees does Orbital Therapeutics have?

Orbital Therapeutics has about 17 employees, unchanged over the 3 months to Sep 2026.

Does Orbital Therapeutics sponsor H1B visas?

Yes. Orbital Therapeutics filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.

What is Orbital Therapeutics's revenue per employee?

Orbital Therapeutics makes about $176K in revenue per employee, based on $3M annual revenue and 17 employees.

How much funding has Orbital Therapeutics raised?

Orbital Therapeutics has raised $270M in total funding; its latest round was Series A in Apr 2023.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.